Syneos Health Appoints Colin Shannon To Succeed Michelle Keefe As CEO

RTTNews | 591 days ago
Syneos Health Appoints Colin Shannon To Succeed Michelle Keefe As CEO

(RTTNews) - Biopharmaceutical solutions firm Syneos Health, Inc. (SYNH) announced Tuesday that Colin Shannon has been appointed Chief Executive Officer, effective immediately. Shannon succeeds Michelle Keefe, who will continue her tenure with Syneos Health as a key member of the Executive Leadership Team. Shannon and Keefe will remain on the Board of Directors.

Shannon brings decades of leadership experience driving growth at global biopharmaceutical solutions organizations. During his 14 years at PRA Health Sciences, Shannon served in executive roles, most recently as Chairman and CEO.

Prior to PRA Health Sciences, he held various executive roles at Pharmaceutical Product Development Inc., including EVP of Global Clinical Operations, COO and CFO of Europe and Chief Financial and Administrative Officer for International Operations.

Keefe served as CEO of Syneos Health for the last 18 months, driving the Company's ongoing transformation and leading the organization through the successful going private transaction.

read more
Syneos Health To Be Taken Private By Private Equity Consortium In $7.1 Bln Deal

Syneos Health To Be Taken Private By Private Equity Consortium In $7.1 Bln Deal

Biopharmaceutical solutions firm Syneos Health, Inc. (SYNH) announced Wednesday that it has entered into a definitive agreement to be acquired by a consortium of private investment firm affiliates composed of Elliott Investment Management, Patient Square Capital, and Veritas Capital for $43.00 per share in cash in a transaction valued at approximately $7.1 billion, including outstanding debt.
RTTNews | 737 days ago
EU Seeks Public Feedback On Microsoft's Proposed Changes To Teams In Antitrust Probe

EU Seeks Public Feedback On Microsoft's Proposed Changes To Teams In Antitrust Probe

The European Commission has invited public response regarding Microsoft Corp.'s offers to address competition concerns related to Teams. In a statement, the EU agency noted that the tech major has offered commitments, among others, to sell its Office product without communication and collaboration product Teams at a lower price than Office with Teams.
RTTNews | 2 minutes ago
Bay Street Likely To Extend Gains

Bay Street Likely To Extend Gains

Canadian shares are likely to extend recent gains as the mood is likely to remain positive Friday morning amid easing tensions about tariffs.
RTTNews | 4 minutes ago
FTSE 100 Advances Again

FTSE 100 Advances Again

U.K. stocks are moving higher on Friday as investors continue to cheer the recent tariff agreement between U.S. and China, and news about a positive progress in talks between the EU bloc and U.S. for lowering the tariffs from earlier proposed levels.
RTTNews | 2h 4min ago
CAC 40 Advances On Easing Trade Tensions

CAC 40 Advances On Easing Trade Tensions

French stocks are up in positive territory on Friday, extending gains from the previous session, amid easing fears of a trade war. Following announcements of U.S.-UK pact, and U.S.-China deal, reports about a positive progress in the EU bloc's discussions with the U.S. for considerable tariff reductions have bolstered investor sentiment.
RTTNews | 2h 32min ago
DAX Up 0.8%, Looks Set To End Week On Strong Note

DAX Up 0.8%, Looks Set To End Week On Strong Note

German stocks are up firmly in positive territory on Friday, amid easing trade tensions following the U.S.-China deal earlier in the week, and recent reports about a positive progress in the EU bloc's discussions with the U.S. for tariff reductions.
RTTNews | 2h 50min ago